CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent

• A. Macedo,
• C.M. Assis,
• C.L. Novis,
• A. Spivak,
• V. Planelles,
• A. Bosque

Affiliations

A. Macedo

Department of Pathology, University of Utah, Salt Lake City, UT, USA

C.M. Assis

Department of Pathology, University of Utah, Salt Lake City, UT, USA

C.L. Novis

Department of Pathology, University of Utah, Salt Lake City, UT, USA

A. Spivak

Department of Medicine, University of Utah, Salt Lake City, UT, USA

V. Planelles

Department of Pathology, University of Utah, Salt Lake City, UT, USA

A. Bosque

Department of Pathology, University of Utah, Salt Lake City, UT, USA